Search Results - "van den Broek, Brigitte T.A."

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
  2. 2

    Quantifying lymphocyte vacuolization serves as a measure of CLN3 disease severity by Kuper, Willemijn F. E., Oostendorp, Marlies, van den Broek, Brigitte T. A., van Veghel, Karin, Nonkes, Lourens J. P., Nieuwenhuis, Edward E. S., Fuchs, Sabine A., Veenendaal, Tineke, Klumperman, Judith, Huisman, Albert, Nierkens, Stefan, van Hasselt, Peter M.

    Published in JIMD reports (01-07-2020)
    “…Background The CLN3 disease spectrum ranges from a childhood‐onset neurodegenerative disorder to a retina‐only disease. Given the lack of metabolic disease…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Emotional consequences of intensive care unit delirium and delusional memories after intensive care unit admission: A systematic review by Nouwen, Marinus J., MD, Klijn, Francina A.M., MD, van den Broek, Brigitte T.A, Slooter, Arjen J.C., MD, PhD

    Published in Journal of critical care (01-04-2012)
    “…Abstract Purpose The aim of this study was to review literature exploring the emotional consequences of delirium and delusional memories in intensive care unit…”
    Get full text
    Journal Article
  5. 5

    Hearing loss in patients with mucopolysaccharidoses‐1 and ‐6 after hematopoietic cell transplantation: A longitudinal analysis by Broek, Brigitte T. A., Smit, Adriana L., Boelens, Jaap Jan, Hasselt, Peter M.

    Published in Journal of inherited metabolic disease (01-11-2020)
    “…Hearing loss is frequently seen in mucopolysaccharidoses (MPS) patients. Although hematopoietic cell transplantation (HCT) increases overall survival, disease…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Hurdles in treating Hurler disease: potential routes to achieve a “real” cure by van den Broek, Brigitte T.A., van Doorn, Jaap, Hegeman, Charlotte V., Nierkens, Stefan, Lindemans, Caroline A., Verhoeven-Duif, Nanda, Boelens, Jaap Jan, van Hasselt, Peter M.

    Published in Blood advances (23-06-2020)
    “…Mucopolysaccharidoses (MPSs) are multiorgan devastating diseases for which hematopoietic cell transplantation (HCT) and, to a lesser extent, enzyme replacement…”
    Get full text
    Journal Article
  10. 10

    Long-term effect of hematopoietic cell transplantation on systemic inflammation in patients with mucopolysaccharidoses by van den Broek, Brigitte T.A., Lindemans, Caroline A., Boelens, Jaap Jan, Delemarre, Eveline M., Drylewicz, Julia, Verhoeven-Duif, Nanda, van Hasselt, Peter M., Nierkens, Stefan

    Published in Blood advances (24-08-2021)
    “…Mucopolysaccharidoses (MPS) are devastating inherited diseases treated with hematopoietic cell transplantation (HCT). However, disease progression, especially…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Salivary α-Iduronidase Activity as a Potential New Biomarker for the Diagnosis and Monitoring the Effect of Therapy in Mucopolysaccharidosis Type I by van Doorn, Jaap, van den Broek, Brigitte T.A., Geboers, Ans J., Kuiper, Gé-Ann, Boelens, Jaap J., van Hasselt, Peter M.

    “…•Salivary IDUA activity is a powerful method to detect IDUA deficiency.•Salivary IDUA activity might be able to differentiate between phenotypes.•Salivary IDUA…”
    Get full text
    Journal Article
  15. 15
  16. 16